{
    "clinical_study": {
        "@rank": "125979", 
        "brief_summary": {
            "textblock": "A multe-center, non-interventional study in Europe to evaluate Pliaglis in dialy practice"
        }, 
        "brief_title": "A Non-interventional Study to Evaluate the Use of Pliaglis in Daily Practice", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Health Knowledge, Attitudes, Practice", 
        "detailed_description": {
            "textblock": "A multi-center, non-interventional study, including up to 700 subjects at approximately 70\n      sites in 5 European countries to evaluate the post-market safety profile of Pliaglis and the\n      efficacy of Pliaglis in terms of pain reduction, satisfaction with the product and daily\n      practice use prior to pre-defined aesthetic procedures."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signed informed consent\n\n          -  Patient treated with Pliaglis by the Investigator or other healthcare professional\n             according to label (refer to SmPC)\n\n          -  Patient had already consented to receive any one or more of the following aesthetic\n             procedures after Pliaglis administration:\n\n               1. Pulsed-dye laser therapy\n\n               2. Laser-assisted hair removal\n\n               3. Non-ablative laser resurfacing\n\n               4. Dermal filler injection\n\n               5. Vascular access\n\n        Exclusion Criteria:\n\n          -  Patient treated with other injectable or topical anaesthetic(s) for the pre-defined\n             aesthetic procedure\n\n          -  Previous participation in this study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patient aiming to perform one or more of the following aesthetic procedures:\n\n          1. Pulsed-dye laser therapy\n\n          2. Laser-assisted hair removal\n\n          3. Non-ablative laser resurfacing\n\n          4. Dermal filler injection\n\n          5. Vascular access"
            }
        }, 
        "enrollment": {
            "#text": "700", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01800474", 
            "org_study_id": "05PT1209"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 8, 2013", 
        "location": {
            "contact": {
                "email": "max.murison@btconnect.com", 
                "last_name": "Max Murison, Dr.", 
                "phone": "01267 281905"
            }, 
            "facility": {
                "address": {
                    "city": "Swansea", 
                    "country": "United Kingdom", 
                    "zip": "SA7 9FH"
                }, 
                "name": "Swansea Laser Clinic"
            }, 
            "investigator": {
                "last_name": "Max Murison, Dr.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Non-interventional Study to Evaluate the Use of Pliaglis in Daily Practice", 
        "overall_official": {
            "affiliation": "National coordinating investigator", 
            "last_name": "Max Murison, Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Post-market safety profile of Pliaglis assessed on spontaneously reported Adverse Reactions", 
            "safety_issue": "Yes", 
            "time_frame": "After Pliaglis application and throughout the site visit (day of application)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01800474"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Pain intensity by VAS, satisfaction with pain reduction, willingness to re-use/recommend Pliaglis", 
            "measure": "Efficacy of Pliaglis", 
            "safety_issue": "No", 
            "time_frame": "After completing Pliaglis treatment and procedure, i.e. at the end of the site visit (day of application)"
        }, 
        "source": "Q-Med AB", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Q-Med AB", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}